浙江金华康恩贝生物制药有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
143
NMPA:143
Drug Approvals
Terbutaline Sulfate Solution for Nebulization
- Product Name
- 硫酸特布他林雾化吸入用溶液
- Approval Number
- 国药准字H20253090
- Approval Date
- Jan 8, 2025
NMPA
Ipratropium Bromide Solution for Inhalation
- Product Name
- 吸入用异丙托溴铵溶液
- Approval Number
- 国药准字H20253088
- Approval Date
- Jan 8, 2025
NMPA
Parecoxib Sodium for Injection
- Product Name
- 注射用帕瑞昔布钠
- Approval Number
- 国药准字H20203115
- Approval Date
- Sep 14, 2024
NMPA
Bismuth Subcarbonate Tablets
- Product Name
- 碱式碳酸铋片
- Approval Number
- 国药准字H33021565
- Approval Date
- Sep 3, 2024
NMPA
Domiphen Bromide Buccal Tablets
- Product Name
- 度米芬含片
- Approval Number
- 国药准字H33022073
- Approval Date
- Aug 23, 2024
NMPA
Tinidazole Vaginal Effervescent Tablets
- Product Name
- 替硝唑阴道泡腾片
- Approval Number
- 国药准字H10980105
- Approval Date
- Aug 23, 2024
NMPA
Bismuth Subnitrate Tablets
- Product Name
- 碱式硝酸铋片
- Approval Number
- 国药准字H33020550
- Approval Date
- Aug 23, 2024
NMPA
Ampicillin Sodium and Sulbactam Sodium for Injection
- Product Name
- 注射用氨苄西林钠舒巴坦钠
- Approval Number
- 国药准字H20013180
- Approval Date
- Aug 9, 2024
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 15
- Next
Clinical Trials
No trials found
News
No news found